Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1800 (-2.91%) ($7.1450 - $7.1800) on Thu. Jul. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 59 | Latest Price | $7.1800(-2.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(32%) BND(24%) VCIT(24%) BNDX(22%) SHY(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.41% in a week (0% probabilities). XLRE(-32%) XLP(-28%) DIA(-25%) XLI(-22%) SPLV(-22%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.22(-0.55%) | 10 Day Moving Average | $7.22(-0.55%) | 20 Day Moving Average | $7.13(0.7%) | To recent high | -18.9% | To recent low | 3.5% | Market Cap | $1.267b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |